Why is Brooks Lab. falling/rising?

As of 28-Jul, Brooks Laboratories Ltd is experiencing a slight decline in its stock price, currently at 152.00, which reflects a decrease of 0.1 or 0.07%. The stock has been losing value for the last two days, with a total drop of 2.06% during this period. Despite being higher than the 20-day, 50-day, 100-day, and 200-day moving averages, it is lower than the 5-day moving average. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 43.58% against the 5-day average. While the company has shown strong performance in the long term, with a 65.40% return over the past year, its weak long-term fundamentals, including an average Return on Equity (ROE) of 0% and poor growth in net sales, are contributing to the current downward pressure on the stock.
In the broader market context, Brooks Laboratories Ltd's short-term performance has been underwhelming compared to the benchmark, with a 4.82% decline over the past week against a 1.59% drop in the Sensex. This indicates that the stock is not only struggling in isolation but is also lagging behind the market trend. The company's ability to service its debt is weak, and it has a very expensive valuation with a Price to Book Value of 4.6, despite trading at a discount compared to its peers. These factors, combined with the recent decline in investor interest and the stock's performance relative to the benchmark, suggest that the market sentiment is currently negative towards Brooks Laboratories Ltd.